These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12136642)

  • 1. [Synthesis of biomimetic analogs of neomycin B].
    Nishizono N
    Yakugaku Zasshi; 2002 Jul; 122(7):465-9. PubMed ID: 12136642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of biomimetic analogs of neomycin B: potential inhibitors of the HIV RNA Rev response element.
    Nishizono N; Nair V
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):283-95. PubMed ID: 10772716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-canonical base pair within the human immunodeficiency virus rev-responsive element is involved in both rev and small molecule recognition.
    Werstuck G; Zapp ML; Green MR
    Chem Biol; 1996 Feb; 3(2):129-37. PubMed ID: 8807838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production.
    Zapp ML; Stern S; Green MR
    Cell; 1993 Sep; 74(6):969-78. PubMed ID: 8402886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of neomycin and Rev peptide binding to the Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy.
    Lacourciere KA; Stivers JT; Marino JP
    Biochemistry; 2000 May; 39(19):5630-41. PubMed ID: 10801313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct observation of aminoglycoside-RNA interactions by surface plasmon resonance.
    Hendrix M; Priestley ES; Joyce GF; Wong CH
    J Am Chem Soc; 1997 Apr; 119(16):3641-8. PubMed ID: 11540136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycoside antibiotics, neamine and its derivatives as potent inhibitors for the RNA-protein interactions derived from HIV-1 activators.
    Hamasaki K; Ueno A
    Bioorg Med Chem Lett; 2001 Feb; 11(4):591-4. PubMed ID: 11229778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of neomycin analogues for HIV-1 RRE RNA recognition identifies enhanced activity simplified neamine analogues.
    Simon B; Walmsley C; Jackson VJ; Garvey EP; Slater MJ; Berrisford DJ; Gardiner JM
    Bioorg Med Chem Lett; 2019 Jan; 29(2):339-341. PubMed ID: 30477891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alpha-helical peptidomimetic inhibitor of the HIV-1 Rev-RRE interaction.
    Mills NL; Daugherty MD; Frankel AD; Guy RK
    J Am Chem Soc; 2006 Mar; 128(11):3496-7. PubMed ID: 16536504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The herpes simplex virus 1 Us11 protein cooperates with suboptimal amounts of human immunodeficiency virus type 1 (HIV-1) Rev protein to rescue HIV-1 production.
    Duc Dodon M; Mikaélian I; Sergeant A; Gazzolo L
    Virology; 2000 Apr; 270(1):43-53. PubMed ID: 10772978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity in the binding of aminoglycosides to HIV-RRE RNA.
    Cho J; Rando RR
    Biochemistry; 1999 Jun; 38(26):8548-54. PubMed ID: 10387102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives.
    Ratmeyer L; Zapp ML; Green MR; Vinayak R; Kumar A; Boykin DW; Wilson WD
    Biochemistry; 1996 Oct; 35(42):13689-96. PubMed ID: 8885849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
    Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
    J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HIV-1 Rev and related inhibitors].
    Cao Y; Liu XY
    Yao Xue Xue Bao; 2007 Apr; 42(4):347-51. PubMed ID: 17633198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein.
    Tiley LS; Malim MH; Tewary HK; Stockley PG; Cullen BR
    Proc Natl Acad Sci U S A; 1992 Jan; 89(2):758-62. PubMed ID: 1731351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities.
    Litovchick A; Lapidot A; Eisenstein M; Kalinkovich A; Borkow G
    Biochemistry; 2001 Dec; 40(51):15612-23. PubMed ID: 11747436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
    Nam YS; Petrovic A; Jeong KS; Venkatesan S
    J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proflavine acts as a Rev inhibitor by targeting the high-affinity Rev binding site of the Rev responsive element of HIV-1.
    DeJong ES; Chang CE; Gilson MK; Marino JP
    Biochemistry; 2003 Jul; 42(26):8035-46. PubMed ID: 12834355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of HIV Rev peptides with the Rev response element RNA.
    Williamson JR; Battiste JL; Mao H; Frankel AD
    Nucleic Acids Symp Ser; 1995; (33):46-8. PubMed ID: 8643394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.